From: Differences in serum oxidative status between glaucomatous and nonglaucomatous cataract patients
Glaucoma + Cataract | Cataract | p | |
---|---|---|---|
Malondialdehyde | 1.16 μmol/l SD: 0.54; 95% CI: 0.96–1.36 | 0.757 μmol/l SD: 0.13 95% CI: 0.70–0.81 | p = 0.005 |
Lipofuscine | 1636.27 RF SD: 325.03 95% CI: 1514.90–1757.64 | 1298.84 RF SD: 241.59 95% CI: 1201.26–1396.42 | p = 0.000 |
Total SODa | 17.48 NU/ml SD: 3,12 95% CI: 16,3–18,6 | 20,43 NU/ml SD: 4,03 95% CI: 18,80–22,06 | p = 0.003 |
Cytosolic SODa | 8.87 NU/ml SD: 2.44 | 9.84 NU/ml SD: 2.20 | NS |
Mitochondrial SODa | 8.61 NU/ml SD: 2.04 | 10.59 NU/ml SD: 3.49 | p = 0.048 |
Total Oxidative State | 22.81 μmol/l SD: 26,44; 95% CI: 12,94–32,68 | 8.08 μmol/l SD: 5,82; 95% CI: 4,71–9,35 | p = 0.016 |
Total Antioxidant Capacity | 1.03 mmol/l SD: 0,19; 95% CI: 0,96–1,10 | 1.02 mmol/l SD: 0,09; 95% CI: 0,98–1,06 | NS |